User menu

Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults.

Bibliographic reference Moutschen, Michel ; Léonard, Philippe ; Sokal, Etienne ; Smets, Françoise ; Haumont, Michèle ; et. al. Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults.. In: Vaccine, Vol. 25, no. 24, p. 4697-705 (2007)
Permanent URL http://hdl.handle.net/2078.1/25701